Investors can access the financial summary at 3:45 a.m. Pacific Daylight Time on the company's news portal. A live webcast detailing these results is set to follow from 5:45 to 6:30 a.m. PDT via the MiniMed investor relations website. For those unable to join the live session, a full transcript and audio replay will be posted within 24 hours of the broadcast.

MiniMed maintains a global presence in insulin delivery systems and continuous glucose monitoring. The upcoming report will provide insight into the company's integrated ecosystem, which currently serves patients across more than 80 countries. Any projections regarding future performance remain subject to standard market risks and uncertainties as filed with the Securities and Exchange Commission.